Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Willekens · SciRah

Researcher profile · Semantic Scholar

C. Willekens

Share profile

C. Willekens — researcher profile on SciRah

h-index: 26
Works: 105
Citations: 5,311

Most-cited papers

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia.
E. Stein, C. Dinardo, D. Pollyea, A. Fathi +23 more
2017Blood1,383 citations Open access
Semantic Scholar
Durable Remissions with Ivosidenib in IDH1‐Mutated Relapsed or Refractory AML
C. Dinardo, E. Stein, S. de Botton, G. Roboz +36 more
2018New England Journal of Medicine1,315 citations Open access
Semantic Scholar
ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia.
T. Maes, C. Mascaró, I. Tirapu, Angels Estiarte +17 more
2018Cancer Cell276 citations Open access
Semantic Scholar
Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia.
Dorothée Sélimoglu-Buet, O. Wagner-Ballon, V. Saada, V. Bardet +17 more
2015Blood250 citations Open access
Semantic Scholar
IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives
J. Mondesir, C. Willekens, Mehdi Touat, S. de Botton
2016Journal of Blood Medicine205 citations Open access
Semantic Scholar
Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor Enasidenib
L. Quek, M. David, Alison Kennedy, M. Metzner +21 more
2018Nature Medicine176 citations Open access
Semantic Scholar
Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers
F. Danlos, Claudia Grajeda-Iglesias, S. Durand, A. Sauvat +36 more
2021Cell Death and Disease150 citations Open access
Semantic Scholar
Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort
L. Albiges, S. Foulon, A. Bayle, B. Gachot +27 more
2020Nature Cancer113 citations Open access
Semantic Scholar
Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial
C. Willekens, O. Blanchet, Aline Renneville, P. Cornillet-Lefebvre +7 more
2015Haematologica108 citations Open access
Semantic Scholar
Enasidenib in mutant IDH 2 relapsed or refractory acute myeloid leukemia
E. Stein, C. Dinardo, D. Pollyea, A. Fathi +23 more
2017102 citations
Semantic Scholar
Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia
Nolwenn Lucas, M. Duchmann, P. Rameau, Floriane Noël +19 more
2019Leukemia99 citations
Semantic Scholar
Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening
T. Hueso, Kenneth Ekpe, C. Mayeur, Anna Gatse +18 more
2020Gut microbes74 citations Open access
Semantic Scholar
First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia
O. Salamero, P. Montesinos, C. Willekens, J. Pérez-Simón +12 more
2020Journal of Clinical Oncology72 citations Open access
Semantic Scholar
Rituximab–cyclophosphamide–dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia
Julien Rossignol, A. Michallet, L. Obéric, M. Picard +6 more
2011Leukemia67 citations
Semantic Scholar
CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model
Y. Zhang, S. Patel, H. Abdelouahab, M. Wittner +15 more
2012Cell Death and Disease64 citations Open access
Semantic Scholar
JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation.
R. Besancenot, Damien Roos-Weil, C. Tonetti, H. Abdelouahab +10 more
2014Blood63 citations Open access
Semantic Scholar
RAS mutations in myeloid malignancies: revisiting old questions with novel insights and therapeutic perspectives
Dana Alawieh, Leila Cysique-Foinlan, C. Willekens, Aline Renneville
2024Blood Cancer Journal61 citations Open access
Semantic Scholar
A miR-150/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset
Dorothée Sélimoglu-Buet, J. Rivière, H. Ghamlouch, Laura Bencheikh +15 more
2018Nature Communications49 citations Open access
Semantic Scholar
Outcome of patients with high risk Myelodysplastic Syndrome (MDS) and advanced Chronic Myelomonocytic Leukemia (CMML) treated with decitabine after azacitidine failure.
S. Harel, Amina Cherait, C. Berthon, C. Willekens +9 more
2015Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis48 citations
Semantic Scholar
Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia‐associated autoimmune hemolytic anemia: A multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS)
A. Quinquenel, C. Willekens, J. Dupuis, B. Royer +7 more
2015American journal of hematology/oncology45 citations Open access
Semantic Scholar
Abstract CT403: Outcome of cancer patients infected with COVID-19, including toxicity of cancer treatments
F. Barlesi, S. Foulon, A. Bayle, B. Gachot +14 more
202041 citations
Semantic Scholar
Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal type.
J. Michot, R. Mazeron, A. Danu, J. Lazarovici +13 more
2015European Journal of Cancer35 citations
Semantic Scholar
Safety, Phamacokinetics (PK), Pharmacodynamics (PD) and Preliminary Activity in Acute Leukemia of Ory-1001, a First-in-Class Inhibitor of Lysine-Specific Histone Demethylase 1A (LSD1/KDM1A): Initial Results from a First-in-Human Phase 1 Study
T. Somervaille, O. Salamero, P. Montesinos, C. Willekens +8 more
201634 citations
Semantic Scholar
Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors
Nicolas Duployez, C. Willekens, A. Marceau-Renaut, Elise Boudry-Labis +1 more
2015Expert Review of Hematology32 citations
Semantic Scholar
Reduced Venetoclax Exposition to Seven Days of Azacitidine Is Efficient in Treatment-Naïve Patients with Acute Myeloid Leukemia
C. Willekens, Samy Chraibi, J. Decroocq, B. Carpentier +18 more
2022Blood28 citations Open access
Semantic Scholar
Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokines.
Yan-Yan Zhang, Liang He, Dorothée Sélimoglu-Buet, C. Jego +8 more
2017Blood Advances28 citations Open access
Semantic Scholar
Prognostic value of PINI index in patients with multiple myeloma
S. Dupire, M. Wémeau, H. Debarri, L. Pascal +11 more
2012European Journal of Haematology26 citations
Semantic Scholar
5-Azacitidine in Patients with IDH1/2-mutant Recurrent Glioma.
Laetitia Federici, L. Capelle, Maxime Annereau, F. Bielle +10 more
2020Neuro-Oncology25 citations Open access
Semantic Scholar
Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1‐RUNX1T1 fusion quantification on genomic DNA
Nicolas Duployez, O. Nibourel, A. Marceau-Renaut, C. Willekens +10 more
2014American journal of hematology/oncology24 citations Open access
Semantic Scholar
Fulminant hemophagocytic lymphohistiocytosis induced by pandemic A (H1N1) influenza: a case report
C. Willekens, A. Cornélius, M. Guerry, A. Wacrenier +1 more
2011Journal of Medical Case Reports24 citations Open access
Semantic Scholar
Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study
S. Kayser, R. Schlenk, D. Lebon, M. Carré +47 more
2021Haematologica22 citations Open access
Semantic Scholar
AG-221, an Oral, Selective, First-in-Class, Potent IDH2-R140Q Mutant Inhibitor, Induces Differentiation in a Xenotransplant Model
C. Quivoron, M. David, Kimberly S. Straley, J. Travins +15 more
201420 citations
Semantic Scholar
Molecular Landscape of Therapy-related Myeloid Neoplasms in Patients Previously Treated for Gynecologic and Breast Cancers
S. Khalife-Hachem, K. Saleh, F. Pasquier, C. Willekens +17 more
2021HemaSphere19 citations Open access
Semantic Scholar
Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1/2 mutations
C. Willekens, Aline Renneville, S. Broutin, V. Saada +14 more
2018Leukemia19 citations
Semantic Scholar
Linezolid induces ring sideroblasts
C. Willekens, F. Dumézy, T. Boyer, Aline Renneville +6 more
2013Haematologica19 citations Open access
Semantic Scholar
SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice
C. Willekens, L. Laplane, Tracy Dagher, Camélia Benlabiod +22 more
2023Leukemia17 citations Open access
Semantic Scholar
Inherited transmission of the CSF3R T618I mutational hotspot in familial chronic neutrophilic leukemia.
Nicolas Duployez, C. Willekens, I. Plo, A. Marceau-Renaut +9 more
2019Blood17 citations Open access
Semantic Scholar
Radioimmunotherapy (90Y‐Ibritumomab Tiuxetan) for Posttransplant Lymphoproliferative Disorders After Prior Exposure to Rituximab
J. Rossignol, L. Terriou, D. Robu, C. Willekens +7 more
2015American Journal of Transplantation15 citations Open access
Semantic Scholar
Invasive cutaneous infection due to Scopulariopsis brevicaulis unsuccessfully treated with high-dose micafungin in a neutropenic patient
Daniel Gavril, P. Woerther, A. Ben Lakhdar, L. Mahjoubi +6 more
2017Infection14 citations
Semantic Scholar
An Unusual Case of Constitutional Mismatch Repair Deficiency Syndrome With Anaplastic Ganglioglioma, Colonic Adenocarcinoma, Osteosarcoma, Acute Myeloid Leukemia, and Signs of Neurofibromatosis Type 1: Case Report.
B. Daou, M. Zanello, P. Varlet, L. Brugières +9 more
2015Neurosurgery12 citations
Semantic Scholar
Plitidepsin: an orphan drug
A. Danu, C. Willekens, V. Ribrag
201310 citations
Semantic Scholar
RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies
C. Bigenwald, Yacine Haddad, Cassandra Thelemaque, Agathe Carrier +16 more
2023Oncoimmunology8 citations Open access
Semantic Scholar
High‐dose cyclophosphamide for hard‐to‐treat patients with relapsed or refractory B‐cell non‐Hodgkin's lymphoma, a phase II result
J. Michot, M. Annereau, A. Danu, Clémence Legoupil +12 more
2019European Journal of Haematology8 citations
Semantic Scholar
Next-generation sequencing discriminates myelodysplastic/myeloproliferative neoplasms from paraneoplastic leukemoid reaction in cancer patients with hyperleukocytosis
R. Sakr, Aline Renneville, V. Saada, S. Cotteret +12 more
2018Leukemia and Lymphoma7 citations
Semantic Scholar
Treatment With Decitabine (DAC) After Azacitidine (AZA) Failure In High Risk Myelodysplastic Syndrome (MDS) and Advanced Chronic Myelomonocytic Leukemia (CMML)
Amina Cherait, C. Berthon, C. Willekens, Sophie Park +8 more
20137 citations
Semantic Scholar
A retrospective comparison of abbreviated course “7+7” vs standard hypomethylating agent plus venetoclax doublets in older/unfit patients with newly diagnosed acute myeloid leukemia.
A. Bazinet, C. Dinardo, Naszrin Arani, A. Bataller +16 more
2024Journal of Clinical Oncology6 citations
Semantic Scholar
Use of 5-azacitidine for therapy-related myeloid neoplasms in patients with concomitant active neoplastic disease.
M. Annereau, C. Willekens, L. El Halabi, C. Chahine +13 more
2017Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis6 citations
Semantic Scholar
ATG2B/GSKIP in de novo acute myeloid leukemia (AML): high prevalence of germline predisposition in French West Indies
Jean Pegliasco, B. Schmaltz-Panneau, J. Martin, Samy Chraibi +23 more
2021Leukemia and Lymphoma5 citations
Semantic Scholar
Effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study
C. Willekens, R. Rahmé, M. Duchmann, V. Vidal +24 more
2020Leukemia and Lymphoma5 citations
Semantic Scholar
Low dose IL-2 in patients with steroid-dependent dysimmune manifestations associated with myelodysplastic syndromes: a three-case report.
Marion Corfmat, C. Willekens, J. Vinit, G. Bussone +5 more
2020Rheumatology5 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. de Botton×20
Invite
S. de Botton — researcher profile on SciRah
J. Micol×13
Invite
J. Micol — researcher profile on SciRah
V. Saada×12
Invite
V. Saada — researcher profile on SciRah
É. Solary×9
Invite
É. Solary — researcher profile on SciRah

Aline Renneville

×8

Invite

Aline Renneville — researcher profile on SciRah

Invite

P. Fenaux — researcher profile on SciRah

C. Preudhomme×7

Invite

C. Preudhomme — researcher profile on SciRah

Invite

N. Droin — researcher profile on SciRah

Invite

K. Yen — researcher profile on SciRah

Invite

S. Agresta — researcher profile on SciRah

Invite

R. Itzykson — researcher profile on SciRah

Invite

B. Quesnel — researcher profile on SciRah